Ronac Mamtani, MD, MSCE

faculty photo
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-308
3400 Civic Center Blvd
Philadelphia, PA 19147
Office: 2156627606
Fax: (215) 349-8551
Cornell University, 2002.
MD (Internal Medicine)
Stony Brook School of Medicine, 2006.
MS (Clinical Epidemiology)
University of Pennsylvania , 2012.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Mamtani R, Lund J, Hubbard RA: Considering the totality of evidence: Combining real‐world data with clinical trial results to better inform decision‐making. Pharmacoepidemiology and Drug Safety 2021.

Shun Yu, Ronac Mamtani, Mark H O'Hara, Peter J O'Dwyer, Ofer Margalit, Bruce J Giantonio, Einat Shmueli, Kim A Reiss, Ben Boursi : Comparative Effectiveness of Total Neoadjuvant Therapy Versus Standard Adjuvant Chemotherapy for Locally Advanced Rectal Cancer. Clin Colorectal Cancer 2021.

Lova Sun,Miles Tan, Roger B. Cohen, Corey J. Langer, Ronac Mamtani*, Charu Aggarwal : Association between KRAS mutational status and outcomes with first-line immune checkpoint based therapy in patients with advanced non small cell lung cancer JAMA Onc 2021 Notes: *Co-senior

Baruch EN, Youngster I, Ben-Betzalel G, Ortenberg R, Lahat A, Katz L, Adler K, Dick-Necula D, Raskin S, Bloch N, Rotin D, Anafi L, Avivi C, Melnichenko J, Steinberg-Silman Y, Mamtani R, Harati H, Asher N, Shapira-Frommer R, Brosh-Nissimov T, Eshet Y, Ben-Simon S, Ziv O, Khan MAW, Amit M, Ajami NJ, Barshack I, Schachter J, Wargo JA, Koren O, Markel G, Boursi B.: Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science 2021.

Vajravelu RK, Mehta SJ, Lewis JD; Early-age Onset Colorectal Cancer Testing, Epidemiology, Diagnosis, and Symptoms Study Group (EOCRC TrEnDS), Karasic TB, Mamtani R, Scott FI.: Understanding Characteristics of Who Undergoes Testing Is Crucial for the Development of Diagnostic Strategies to Identify Individuals at Risk for Early-age Onset Colorectal Cancer. Gastroenterology. 2021.

Kelsey S. Lau-Min, Yimei Li,Jennifer R. Eads, Xiaoliang Wang, Neal J. Meropol, Ronac Mamtani*, and Kelly D. Getz: Adherence to and Determinants of Guideline-Recommended Biomarker Testing and Targeted Therapy in Patients With Gastroesophageal Adenocarcinoma: Insights From Routine Practice. Cancer 2021 Notes: *co-senior author.

Lova Sun, Sanjna Surya, Anh N Le, Heena Desai, Abigail Doucette, Peter Gabriel, Marylyn D Ritchie, Daniel Rader, Ivan Maillard, Erin Bange, Alexander C Huang, Robert H Vonderheide, Angela DeMichele, Anurag Verma, Ronac Mamtani, Kara N Maxwell: Rates of COVID-19-Related Outcomes in Cancer Compared With Noncancer Patients. JNCI Cancer Spectr 2021.

Slater RL, Lai Y, Zhong Y, Li H, Meng Y, Homet Moreno B, Godwin JL, Frenkl T, Sonpavde GP, Mamtani R.: The cost effectiveness of pembrolizumab versus chemotherapy or atezolizumab as second-line therapy for advanced urothelial carcinoma in the United States. J Med Econ May 2020.

Bange EM, Doucette A, Gabriel PE, Porterfield F, Harrigan JJ, Wang R, Wojcieszynski AP, Boursi B, Mooney BI, Reiss KA, Mamtani R.: Opportunity Costs of Receiving Palliative Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma. JCO Oncol Pract March 2020.

Takvorian SU, Oganisian A, Mamtani R, Mitra N, Shulman LN, Bekelman JE, Werner RM.: Association of Medicaid Expansion Under the Affordable Care Act With Insurance Status, Cancer Stage, and Timely Treatment Among Patients With Breast, Colon, and Lung Cancer. JAMA Netw Open Feb 2020.

back to top
Last updated: 03/12/2021
The Trustees of the University of Pennsylvania